Rita Shaknovich, a hematopathologist and physician scientist, emphasizes the evolution of molecular diagnostics and its implications in precision medicine. With a focus on simplifying complex workflows, Shaknovich advocates for decentralized access to advanced diagnostic technologies, especially in underserved areas. She highlights the transformative potential of AI and machine learning in enhancing the interpretive capabilities of diagnostics. Furthermore, she calls for increased funding for chronic diseases and rare conditions, alongside an expansion in the use of liquid biopsies and multi-omics approaches to improve patient outcomes.
Industry Insights: Pride in Precision Medicine
Rita Shaknovich, Chief Medical Officer at Agilent Technologies, shares her insights into automation, access, and analytics
10/21/2025
Interview
5 min read
